<DOC>
	<DOCNO>NCT01199484</DOCNO>
	<brief_summary>Background : Limited publish evidence show specific oral tolerance induction ( SOTI ) potential intervention option cow 's milk protein ( CMPs ) allergy . Our hypothesis SOTI start early order improve efficacy prevent CMPs sensitization evolve towards persistent allergy . The aim study evaluate safety efficacy SOTI 2-year-old child cow 's milk allergy , treatment alternative elimination diet . Methods : A total 60 child 24-36 month age IgE-mediated allergy CMPs include multicenter study randomly divide two different group . Thirty child ( group A : treatment group ) begin SOTI immediately , whereas remain 30 ( group B : control group ) keep milk-free diet followed-up one year .</brief_summary>
	<brief_title>Specific Oral Tolerance Induction Cow 's Milk Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Milk Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<criteria>1 . Infants 2436 month age . 2 . IgEmediated allergy CMPs meeting follow diagnostic criterion : Immediatetype clinical manifestation , skin ( urticaria , angioedema and/or erythema ) , digestive ( acute vomit and/or diarrhea ) respiratory ( bronchospasm and/or rhinitis ) involvement first two hour cow 's milk ingestion . Skin test reading ≥ 3 mm specific IgE titer &gt; 0.35 kU/l whole cow 's milk someone isolate CMPs ( casein , alphalactalbumin , betalactoglobulin ) 3 . Persistence CMP allergy four week prior tolerance induction , base follow criterion : Skin ( prick ) test reading ≥3 mm specific IgE titer ( CAPFEIA ) &gt; 0.35 kU/l whole cow 's milk someone isolate CMPs ( casein , alphalactalbumin , betalactoglobulin ) Doubleblind placebocontrolled challenge ( DBPCFC ) positive cow 's milk . 4 . Written inform consent parent . 1 . Clinical manifestation anaphylactic shock ingestion cow 's milk . 2 . NonIgEmediated nonimmunological adverse reaction cow 's milk . 3 . Malignant immunopathological disease and/or severe primary secondary immune deficiency . 4 . Patients receive immunosuppressor therapy . 5 . Patients receive betablockers ( include topical formulation ) . 6 . Associated disease contraindicate use adrenalin : cardiovascular disease severe hypertension</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Cow 's milk allergy</keyword>
	<keyword>food allergy</keyword>
	<keyword>oral desensitization</keyword>
	<keyword>randomize trial</keyword>
	<keyword>specific oral tolerance induction .</keyword>
</DOC>